Multi-drug Resistant Tuberculosis in india

1224 Words3 Pages

The prevalence of multi-drug resistant tuberculosis has not only impacted India it has impacted other countries like Africa. Multi-drug resistant tuberculosis is when the regular medicine such as isoniazid and rifampicin one of the two anti-tuberculosis drugs used, the resistance can occur either through not following the proper treatment guidelines or from a drug resistant bacteria, tuberculosis can be caused from Mycobacterium Tuberculosis a bacteria that causes tuberculosis which attacks the lungs. Tuberculosis occurs through droplet infection and is extremely contagious, due the nature of being multi-drug resistant (MDR-TB) and extensively drug resistant (XDR-TB) many of the medications are expensive and hard to come by.

MDR-TB is caused by improper adherence to the treatment that the person is said to be on, MDR-TB can also be caused to someone who had a previous case of tuberculosis. The treatment of MDR-TB is expensive and the scarcity of funding is debilitating the further treatment of tuberculosis as well as its different forms, tuberculosis could prove to be fatal if not treated in the appropriate amount of time. The MDR-TB patients had seen weight loss, the amount of time for recuperation for the patients was longer than the time taken for the drug resistant tuberculosis. The availability of cheaper, and less toxic drugs would help with the treatment of tuberculosis as well as better attention in hospitals and other institutions.

India is one of the countries with the most number of XDR-TB cases recorded. The early detection of tuberculosis is expensive but is needed to save the people from dyeing, this problem arises due to the lack of funding provided for the research and treatment of tuberculosis....

... middle of paper ...

... treatment of drug-susceptible and multidrug-resistant tuberculosis." Journal of Infection and Public Health Available online 9 November 2013 (2013): n. pag. ScienceDirect. Web. 24 Nov. 2013.

"Resources." ACTION.org. Global Health Advocacy Leadership, n.d. Web. 23 Nov. 2013. .

"The five elements of DOTS." WHO. WHO, n.d. Web. 23 Nov. 2013. .

"Tuberculosis Diagnositics Xpert MTB/RIF Test." World Health Organization. WHO, n.d. Web. 23 Nov. 2013. .

Prasad, R. "Paediatric TB: should Xpert molecular test replace smear microscopy?." The Hindu. The Hindu, n.d. Web. 23 Nov. 2013. .

More about Multi-drug Resistant Tuberculosis in india

Open Document